ORLOFF JOHN J (EVP, Research & Development) received a stock award from ALEXION PHARMACEUTICALS, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 2 awards
Filed: 7/16/2021ACC: 0000899866-21-000054
Officer· EVP, Research & Development
Since Feb 2019
+60.14K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
2
Total transactions
60.14K acquired
Non-Derivative Transactions2
Common Stock, par value $.0001 per share
Direct
Shares
+30.64K
Price / share
—
Trade value
—
% of position
35.5%
7/14/2021
86.37K→117.01K
Common Stock, par value $.0001 per share
Direct
Shares
+29.50K
Price / share
—
Trade value
—
% of position
25.2%
7/14/2021
117.01K→146.51K
Total
Net shares
+60.14K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $.0001 per share Direct | 7/14/2021 | A · Award | +30.64K | — | — | 35.5% | 86.37K | 117.01K |
| Common Stock, par value $.0001 per share Direct | 7/14/2021 | A · Award | +29.50K | — | — | 25.2% | 117.01K | 146.51K |
| Total | +60.14K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported